Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Rosuvastatin Based on 27 publication(s) in Google Scholar Rosuvastatin (ZD 4522) is a competitive HMG-CoA reductase inhibitor with an IC 50 of 11 nM
PureHealth Research Has Been Featured On: PureHealth Research is not endorsed by, sponsored by, or affiliated with any of these organizations
The most extensively documented involves upregulation of vascular endothelial growth factor (VEGF) and its receptor VEGFR2, promoting angiogenesis, the formation of new blood vessels, in injured tissue
The main mechanisms with research support: Collagen and connective tissue: GHK-Cu upregulates collagen synthesis and metalloproteinases the enzymes that remodel old, damaged collagen
US$ 22.90
US$ 20.00
US$ 27.00
US$ 22.25
US$ 25.52
US$ 21.15
US$ 27.21
US$ 29.53
US$ 27.92
US$ 21.15
![[PROJECT UBW] Winspace SLC 5 MIRAGE (M) S3-Brand-Motomuck](https://cdn.shopify.com/s/files/1/0551/6217/5627/files/9C66E6E5-CC90-476B-8A6D-2B61DD2B4193.jpg?v=1773309412)
